Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation

Endocrinology

Volumn 140, Issue 4, 1999, Pages 1552-1558

  Schleim, K D ^a   Jacks, T ^a   Cunningham, P ^a   Feeney, W ^a   Frazier, E G ^a   Niebauer, G W ^b   Zhang, D ^a   Chen, H ^a   Smith, R G ^a   Hickey, G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; IBUTAMOREN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CORTICOTROPIN BLOOD LEVEL; DOG; DRUG EFFECT; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HYPOPHYSECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS REGULATION;

EID: 0033054061     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.4.6667     Document Type: Article

References (26)

1. 1 Hickey GJ, Jacks TM, Judith FR, Taylor J, Schoen WR, Krupa D, Cunningham P, Clark J, Smith RG 1994 Efficacy and specificity of L-692,429, a novel non-peptidyl growth hormone secretagogue, in beagles. Endocrinology 134:695-701
2. 2. Jacks T, Smith R, Judith F, Schleim K-D, Frazier E, Chen H, Krupa D, Hora Jr D, Nargund R, Patchett A, Hickey G 1996 MK-0677, a potent, novel, orally-active growth hormone (GH) secretagogue: GH, IGF-I and other hormonal responses in beagles. Endocrinology 137:5284-5289
3. 3 Jacks TM, Hickey G, Judith FR, Taylor J, Chen H, Krupa D, Feeney W, Schoen WR, Ok D, Fisher MH, Wyvratt MJ, Smith RG 1994 Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin, and thyroxine (T4) levels in beagles. J Endocrinol 143:399-406
4. 4. Patchett AA, Nargund R, Tata JR, Chen MH, Barakat KL, Jacks T, Schleim K-D, Pong S-S, Chaung L-YP, Chen MY, Frazier E, Leung KH, Chiu S-HL, Smith, Roy G 1995 The design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 92:7001-7005
5. 5. Smith RG, Cheng K, Schoen W, Pong S, Hickey G, Jacks T, Butler B, Chan W, Chaung L, Judith F, Taylor J, Wyvratt MJ, Fisher M 1993 A non-peptidyl growth hormone secretagogue. Science 260:1640-1643
6. 6 Pong S-S, Chaung L-YP, Dean D, Nargund RP, Patchett AA, Smith RG 1996 Identification of a new G-protein linked receptor for growth hormone secretagogues. Mol Endocrinol 10:57-61
7. 7. Berghman LR, Visser TJ, Kuhn ER, Darras VM 1998 Pituitary and extrapituitary action sites of the novel nonpeptidyl growth hormone (GH) secretagogue L-692,429 in the chicken. Gen Comp Endocrinol 111:186-196
8. 8. Cheng K, Chan WWS, Butler B, Wei L, Trumbauer ME, Chen H, Schoen W, Wyvratt Jr MJ, Fisher MH, Smith RG, Mechanism of action of L-692,429, a novel non-peptidyl GH secretagogue, on rat growth hormone release both in vitro and in vivo. 75th Annual Meeting of The Endocrine Society, Las Vegas NV, 1993 (Abstract 988)
9. 9. Chang CH, Rickes EL, Marsilio F, McGuire LA, Hickey GJ, Cosgrove S, Taylor J, Chen H, Feighner S, Clark JN, DeVita R, Schoen W, Wyvratt Jr M, Fisher M, Smith RG 1995 A novel non-peptidyl growth hormone secretagogue L-750,653 which specifically stimulates growth hormone relese in swine. Endocrinology 136:1065-1071
10. 10 Hickey G, Drisco J, Faidley T, Chang C, Anderson LL, Nicholich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cunningham P, Frazier E, Chen H, Laroque P, Smith RG 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 148:371-380
11. 11. Christensen RA, Malinowski K, Scanes CG, Hafs HD 1997 Pulsatile release of somatotropin related to meal feeding and somatotropin response to secretagogues in horses. J Anim Sci 75:2770-2777
12. 12. Chang CH, Rickes EL, McGuire LA, Tata J, Patchett A, Hickey GJ, Effect of steroid implant on GH response after acute treatments with a GH secretagogue L-165,868 or GRF and on IGF-I responses in steer. 89th Annual Meeting of the American Society of Animal Science, Nashville TN, 1997 (Abstract 105)
13. 13. Dahl GE, Russek E, Craig LJ, Chang CH, Hickey GJ, Effect of gonadal steroid on growth hormone release in ovariectomized sheep in response to L-692,585, a novel non-peptidyl GH secretagogue. 26th Annual Meeting of the Society for Neuroscience, Washington DC, 1996 (Abstract 534.1)
14. 14 Gertz BJ, Barrett JS, Eisenhandler R, Krupa D, Wittrich JM, Siebold JR, Schneider SH 1993 Growth hormone response in man to L-692,429, a novel non-peptide mimic of growth hormone releasing peptide-6. J Clin Endocrinol Metab 77:1393-1397
15. 15. Hickey G, Jacks T, Schleim K-D, Frazier E, Chen H, Krupa D, Feeney W, Nargund R, Patchett A, Smith RG 1997 Repeat administration of the growth hormone secretagogue MK-0677 increases and mainains elevated IGF-I levels in beagles. J Endocrinol 152:183-192
16. 16. Niebauer GW, Evans SH 1988 Transsphenoidal hypophysectomy in the dog: a new technique. Vet Surg 17:296-303
17. 17. Niebauer GW, Eigenmann JE, Van Winkle TJ 1990 Study of long-term survival after transsphenoidal hypophysectomy in clinically normal dogs. Am J Vet Res 51:677-681
18. 18. Ascacio-Martinez JA, Barrera-Saladana HA 1994 A dog growth hormone cDNA for a mature protein identical to pig growth hormone. Gene 143:277-280
19. 19. Bowers CY, Alster DK, Frentz JM 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 74:292-298
20. 20. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982
21. 21. Estivariz CF, Ziegler TR 1997 Nutrition and insulin-like growth factor system. Endocrine 1:65-71
22. 22. Nygren J, Thorell A, Brismar K, Karpe F, Ljungqvist O 1997 Short-term hypocaloric nutrition but not bed rest decrease insulin sensitivity and IGF-I bioavailability in healthy subjects: the importance of glucagon. Nutrition 13:945-951
23. 23. Chang CH, Rickes EL, McGuire L, Frazier E, Chen H, Barakat K, Nargund R, Patchett A, Smith RG, Hickey GJ 1996 Growth hormone (GH) and insulin-like growth factor-1 responses after treatments with an oral active GH secretagogue L-163,255 in swine. Endocrinology 137:4851-4856
24. 24. Rickes EL, Chang CH, McGuire LA, Dubreuil P, Hickey GJ 1996 Effect of chronic growth hormone secretagogue treatment on subsequent GRF and L-263,255 stimulated GH response in swine. J Anim Sci [Suppl 1] 74:149 (Abstract 173)
25. 25. Vance ML, Kaiser DL, Martha Jr PM, Furlanetto R, Rivier J, Vale W, Thorner MO 1989 Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy. J Clin Endocrinol Metab 68:22-28
26. 26. Chad T 1990 An Introduction to Radioimmunoassay and Related Techniques, ed 4, chapt 6, Elsevier, New York, p 131